Label: UP AND UP ALLERGY RELIEF- fexofenadine hydrochloride tablet, film coated

  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated May 25, 2022

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Fexofenadine HCl 180 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    •
    runny nose
    •
    itchy, watery eye
    •
    sneezing
    •
    itching of the nose or throat
  • Warnings

    Do not use

    if you have ever had an allergic reaction to this product or any of its ingredients.

    Ask a doctor before use if you have

    kidney disease. Your doctor should determine if you need a different dose.

    When using this product

    •
    do not take more than directed
    •
    do not take at the same time as aluminum or magnesium antacids
    •
    do not take with fruit juices (see Directions)

    Stop use and ask a doctor if

    an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    adults and children 12 years of age and over

    take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours

    children under 12 years of age

    do not use

    adults 65 years of age and older

    ask a doctor

    consumers with kidney disease

    ask a doctor
  • Other information

    •
    do not use if carton is opened or printed foil under cap is broken or missing
    •
    store between 20°-25°C (68°-77°F)
    •
    protect from excessive moisture
    •
    this product meets the requirements of USP Dissolution Test 3
  • Inactive ingredients

    colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide black, iron oxide red, iron oxide yellow, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, titanium dioxide

  • Questions?

    Call 1-888-547-7400

  • Package/Label Principal Display Panel

    Compare to active ingredient in Allegra® Allergy

    non-drowsy allergy relief

    fexofenadine hydrochloride tablets 180 mg/antihistamine

    indoor/outdoor allergy relief

    ● sneezing

    ● runny nose

    ● itchy, watery eyes

    ● itchy nose or throat

    ACTUAL SIZE

    24 HOUR

    150 TABLETS

    150 TABLETS

    allergy relief image
  • INGREDIENTS AND APPEARANCE
    UP AND UP ALLERGY RELIEF 
    fexofenadine hydrochloride tablet, film coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11673-571
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FEXOFENADINE HYDROCHLORIDE (UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V) FEXOFENADINE HYDROCHLORIDE180 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorORANGE (peach) Scoreno score
    ShapeROUNDSize12mm
    FlavorImprint Code 93;7253
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:11673-571-391 in 1 CARTON04/13/201110/31/2022
    130 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:11673-571-951 in 1 CARTON11/02/201108/18/2016
    245 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:11673-571-2215 in 1 CARTON04/26/201102/28/2022
    31 in 1 BLISTER PACK; Type 0: Not a Combination Product
    4NDC:11673-571-751 in 1 CARTON02/16/201205/16/2016
    490 in 1 BOTTLE; Type 0: Not a Combination Product
    5NDC:11673-571-491 in 1 CARTON02/05/201508/31/2021
    540 in 1 BOTTLE; Type 0: Not a Combination Product
    6NDC:11673-571-011 in 1 CARTON03/17/201509/30/2022
    670 in 1 BOTTLE; Type 0: Not a Combination Product
    7NDC:11673-571-762 in 1 CARTON03/16/201504/30/2021
    760 in 1 BOTTLE; Type 0: Not a Combination Product
    8NDC:11673-571-871 in 1 CARTON03/15/201607/31/2018
    8300 in 1 BOTTLE; Type 0: Not a Combination Product
    9NDC:11673-571-471 in 1 CARTON01/30/202001/31/2022
    9150 in 1 BOTTLE; Type 0: Not a Combination Product
    10NDC:11673-571-3360 in 1 BOTTLE; Type 0: Not a Combination Product03/16/201504/30/2021
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07644704/13/2011
    Labeler - Target Corporation (006961700)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!